Patient Privacy in the Digital Age and Disclosure on Social Media

Price: $224 OnDemand


Sign up today for an entire year of unlimited access to relevant, timely professional learning courses, including webinars, eLearning courses and OnDemand offerings, and keep your professional credits up to date. All for just $399.

Learn more about the subscription!



Big Brother has nothing on Mark Zuckerberg. Who needs surveillance cameras when over 1.3 billion people willingly disclose who they are, where they live, what they do for a living and the names (and preferences) of their children, closest friends and pets? Going forward, we can expect even more digital disclosure of personal information, some of it quite sensitive. Facebook Inc. and other high-tech giants, most notably Google Inc. and Apple Inc., are looking to the healthcare field to drive growth. Facebook is reportedly developing health and wellness applications, as well as building virtual patient-support communities. Are patients likely to adopt digital health-care initiatives by the Internet behemoths? And, if so, why? It is hardly a secret that Google can track each query that is made using its search engine or browser, leave identifying cookies on your computer and cross-reference your Internet protocol address to get a pretty good idea of your name, address and phone number. Moreover, social media sites such as Google, YouTube, and Face book have access to a wealth of information about their users and a good deal of latitude regarding how they can use that information. An individual’s collective cyberspace history may be ‘‘far more intimate’’ than expected, revealing a ‘‘detailed portrait of [her] life and interests.’’ In light of this, what do patients possibly stand to gain by sharing their health information in cyberspace?

Privacy concerns, in particular regarding sensitive information about patient health on social media, are likely to increase over time. The trade-off, though, may be significant benefits to patients in the long run.Please join Bloomberg BNA and our expert speakers as they address the benefits and risks of patients sharing their health information in the digital age.

Educational Objectives:
• Explore the benefits and risks of patients sharing their health information in the digital age
• Discuss the adoption of digital health-care initiatives
• Review what information is being shared and how that information can be used

Who would benefit most from attending this program?
Health care provides, practitioners, and patients; lawyers, public and private companies, security regulators.



Sharon Roberg-Perez is a Principal in Robins Kaplan LLP’s Intellectual Property and Technology Litigation Group. She is an M.I.T-trained Ph.D. who leverages over a decade of experience working as a molecular biologist in her legal practice. She serves on the firm’s diversity committee and has been an instructor in the firm’s Exceptional Advocate Training Program. She has been recognized for her professional accomplishments and leadership, being named an “Up and Coming Attorney” by Minnesota Lawyer and a fellow of the Leadership Council on Legal Diversity. Sharon’s practice is focused on biotechnology and medical device patent litigation and licensing. She is also registered to practice before the U.S. Patent & Trademark Office. In the courtroom, she has represented both plaintiffs and defendants in cases involving technologies such as genotyping, DNA fingerprinting, transcatheter heart valves, ICDs, spinal implants, personalized content delivery via smartphones or web browsers, and cosmetic formulations. She has significant experience crafting case strategy, as well as running complex cases and developing claim construction, infringement and validity positions. In addition to her intellectual property practice, she has experience representing pro bono clients in connection with the Children’s Law Center of Minnesota and the Minnesota Advocates for Human Rights. Sharon earned her J.D., summa cum laude, from the University of St. Thomas School of Law. She earned her Bachelor’s Degree, magna cum laude, in Biological Chemistry from Wellesley College. Following her graduate work at M.I.T., she completed a postdoctoral fellowship at Caltech, where she researched the molecular genetics of developing sensory neurons. Over the course of her academic career, she authored several scientific publications and received research fellowships from the National Science Foundation, the National Institutes of Health, and the American Psychological Association. She is a member of the Minnesota bar.


Kristine A. Tietz is an associate at Robins Kaplan LLP. She cuts through complexity to help clients define—and control—the issues at the core of their case.  Kristine focuses her practice in intellectual property litigation, representing clients in patent, copyright, and trademark disputes across a diverse spectrum of industries.  Kristine also advises clients on technology and intellectual property transactions, including patent licensing agreements and acquisitions. Kristine attended law school at William Mitchell College of Law, where she graduated magna cum laude. While in law school, Kristine worked in the law department of a Fortune 50 retailer where she analyzed a variety of issues related to corporate transactions, financial services, and intellectual property. Kristine uses insights gained in-house to provide efficient and practical advice to clients. Prior to law school, Kristine managed marketing programs for a provider of cloud-based supply chain management software. Kristine also worked for a Fortune 50 retailer where she managed vendor compliance programs focused on maximizing supply chain efficiencies. She is a member of the Minnesota bar.